Swirsky Douglas J
SEC CIK 1375884 · EDGAR
BoughtSold
Most active insiders at MXCT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Swirsky Douglas J | CFO | — | $8,316 |
| 2 | Ahuja Parmeet | CFO | — | — |
| 3 | Johnston John Joseph | Dir | — | — |
| 4 | Masoud Maher | Pres, CEO, Dir | — | — |
| 5 | Hemrajani Rekha | Dir | — | — |
| 6 | Al-Wakeel Yasir B. | Dir | — | — |
| 7 | Brooke William W | Dir | — | — |
| 8 | Collins Cynthia | Dir | — | — |
| 9 | Erck Stanley C | Dir | — | — |
| 10 | BALTHROP PATRICK J | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-17 | MXCT | MAXCYTE, INC. | Swirsky Douglas J | CFO | S - Sale | $0.82 | -10.1K | 151.7K | -6% | -$8,316 | |
| 2025-08-13 | 2025-08-13 | MXCT | MAXCYTE, INC. | Swirsky Douglas J | CFO | P - Purchase | $1.29 | +50.0K | 161.8K | +45% | +$64.5K | |
| 2025-03-20 | 2025-03-18 | MXCT | MAXCYTE, INC. | Swirsky Douglas J | CFO | S - Sale | $3.18 | -6,939 | 111.8K | -6% | -$22.1K | |
| D | 2025-03-18 | 2025-03-14 | MXCT | MAXCYTE, INC. | Swirsky Douglas J | CFO | A - Grant | $0.00 | +37.5K | 118.8K | +46% | $0 |
| D | 2024-03-19 | 2024-03-15 | MXCT | MAXCYTE, INC. | Swirsky Douglas J | CFO | A - Grant | $0.00 | +81.2K | 81.2K | New | $0 |
| 2021-09-14 | 2021-09-14 | CLRB | Cellectar Biosciences, Inc. | Swirsky Douglas J | Dir | P - Purchase | $1.04 | +25.0K | 25.0K | New | +$26.0K |
Purchase Sale Sale after option exercise All abbreviations